Nabi Zaheer, Karyampudi Arun, Ramchandani Mohan, Chavan Radhika, Basha Jahangeer, Inavolu Pradev, Darisetty Santosh, Goud Rajesh, Reddy D Nageshwar
Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad, 500 082, India.
J Gastrointest Surg. 2022 Jul;26(7):1352-1361. doi: 10.1007/s11605-022-05330-z. Epub 2022 Apr 26.
There is limited data on long-term outcomes of per-oral endoscopic myotomy (POEM). In this study, we aim to evaluate the efficacy of POEM in patients who completed a minimum follow-up of 5 years.
Data of patients who underwent POEM and completed ≥ 5-year follow-up were analyzed, retrospectively. Primary outcome of study was clinical success (Eckardt ≤ 3) at ≥ 5 years after POEM. Secondary outcomes included predictors of dysphagia and symptomatic gastroesophageal reflux disease (GERD) on long-term follow-up.
Three hundred nineteen patients (males 182, mean age 40.5 ± 14.2 years) completed a median of 73-(60-89) month follow-up. Esophageal motility disorders included idiopathic achalasia (type I 26.6%, type II 60.8%, type III 5.6%) and Jackhammer esophagus or distal esophageal spasm (2.8%). POEM was technically successful in 307 (96.2%) patients. Long-term success was 92.6% (overall), 92.1% (type I), 94.7% (type II), 87.5% (type III), and 75% (Jackhammer esophagus/distal esophageal spasm). Symptomatic GERD and reflux esophagitis were detected in 28.9% and 35.3% patients, respectively. On multivariate analysis, young age and female gender were independent risk factors for recurrent dysphagia (p = 0.037) and symptomatic GERD after POEM (p = 0.025), respectively. Lower post-POEM lower esophageal sphincter pressure was an independent predictor for reflux esophagitis (p = 0.016).
POEM is an effective and durable treatment for achalasia and non-achalasia spastic motility disorders. Young patients and females may be at higher risk for recurrent dysphagia and symptomatic GERD, respectively.
关于经口内镜下肌切开术(POEM)的长期预后数据有限。在本研究中,我们旨在评估POEM对完成至少5年随访患者的疗效。
对接受POEM并完成≥5年随访的患者数据进行回顾性分析。研究的主要结局是POEM术后≥5年的临床成功( Eckardt评分≤3)。次要结局包括长期随访时吞咽困难和症状性胃食管反流病(GERD)的预测因素。
319例患者(男性182例,平均年龄40.5±14.2岁)完成了中位时间为73(60 - 89)个月的随访。食管动力障碍包括特发性贲门失弛缓症(I型26.6%,II型60.8%,III型5.6%)和胡桃夹食管或食管远端痉挛(2.8%)。POEM在307例(96.2%)患者中技术成功。长期成功率为92.6%(总体)、92.1%(I型)、94.7%(II型)、87.5%(III型)和75%(胡桃夹食管/食管远端痉挛)。分别有28.9%和35.3%的患者检测到症状性GERD和反流性食管炎。多因素分析显示,年轻和女性分别是POEM术后复发性吞咽困难(p = 0.037)和症状性GERD(p = 0.025)的独立危险因素。POEM术后较低的食管下括约肌压力是反流性食管炎的独立预测因素(p = 0.016)。
POEM是治疗贲门失弛缓症和非贲门失弛缓症痉挛性动力障碍的有效且持久的方法。年轻患者和女性分别可能有更高的复发性吞咽困难和症状性GERD风险。